All Stories

  1. Synthesis, Cytotoxicity Evaluation, and Computational Insights of Novel 1,4-Diazepane-Based Sigma Ligands
  2. Dysregulation of TDP‐43 intracellular localization and early onset ALS are associated with a TARDBP S375G variant
  3. New piperidine-based derivatives as sigma receptor ligands. Synthesis and pharmacological evaluation
  4. Systematic Analysis of Gene Expression Profiles Controlled by hnRNP Q and hnRNP R, Two Closely Related Human RNA Binding Proteins Implicated in mRNA Processing Mechanisms
  5. RhoGAPp190: A potential player in tbph-mediated neurodegeneration in Drosophila
  6. Essential role of hippocampal noradrenaline in the regulation of spatial working memory and TDP-43 tissue pathology
  7. Role of the Long Non-Coding RNA Growth Arrest-Specific 5 in Glucocorticoid Response in Children with Inflammatory Bowel Disease
  8. Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells
  9. Keratin14 mRNA expression in human pneumocytes during quiescence, repair and disease
  10. Computer-assisted design, synthesis, binding and cytotoxicity assessments of new 1-(4-(aryl(methyl)amino)butyl)-heterocyclic sigma 1 ligands
  11. TBPH/TDP-43 modulates translation of Drosophila futsch mRNA through an UG-rich sequence within its 5′UTR
  12. New neurogenic lipoic-based hybrids as innovative Alzheimer's drugs with σ-1 agonism and β-secretase inhibition
  13. Antimycobacterial activity of new N 1 -[1-[1-aryl-3-[4-(1 H -imidazol-1-yl)phenyl]-3-oxo]propyl]-pyridine-2-carboxamidrazone derivatives
  14. A novelDrosophilamodel of TDP-43 proteinopathies: N-terminal sequences combined with the Q/N domain induce protein functional loss and locomotion defects
  15. Exome sequencing of a colorectal cancer family reveals shared mutation pattern and predisposition circuitry along tumor pathways
  16. TDP-43 affects splicing profiles and isoform production of genes involved in the apoptotic and mitotic cellular pathways
  17. Knockdown of MVK does not lead to changes in NALP3 expression or activation
  18. A novel anti-aldolase C antibody specifically interacts with residues 85–102 of the protein
  19. Evolutionarily Conserved Heterogeneous Nuclear Ribonucleoprotein (hnRNP) A/B Proteins Functionally Interact with Human and Drosophila TAR DNA-binding Protein 43 (TDP-43)
  20. Targeting RNA Binding Proteins Involved in Neurodegeneration
  21. TDP-43 high throughput screening analyses in neurodegeneration: Advantages and pitfalls
  22. Role of Pseudoexons and Pseudointrons in Human Cancer
  23. Tirasemtiv (CK-2017357)
  24. Florbetapir F 18 for brain imaging of beta-amyloid plaques
  25. Small Cytoplasmic Ribonucleoproteins
  26. Splicing in the RNA World
  27. Drosophila Answers to TDP-43 Proteinopathies
  28. TDP-43 Regulates Drosophila Neuromuscular Junctions Growth by Modulating Futsch/MAP1B Levels and Synaptic Microtubules Organization
  29. TDP-43 regulates its mRNA levels through a negative feedback loop
  30. G runs in Cystathionine β-Synthase c.833C/c.844_845ins68 mRNA are splicing silencers of pathogenic 3′ splice sites
  31. Neuropeptides in saliva of subjects with burning mouth syndrome: a pilot study
  32. Nuclear factor TDP-43 can affect selected microRNA levels
  33. Functional mapping of the interaction between TDP-43 and hnRNP A2 in vivo
  34. Dissecting the splicing mechanism of the Drosophila editing enzyme; dADAR
  35. Thrombopoietin and its splicing variants: Structure and functions in thrombopoiesis and beyond
  36. Origin and evolution of the c.844_845ins68/c.833T>C mutations within the cystathionine β-synthase gene in great apes
  37. Aberrant 5′ splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization
  38. Complex splicing control of the human Thrombopoietin gene by intronic G runs
  39. Photodynamic Therapy of Subfoveal Choroidal Neovascularization Secondary to Reticular Pattern Dystrophy: Three-Year Results of an Uncontrolled, Prospective Case Series
  40. Depletion of TDP 43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene
  41. Human, Drosophila, and C.elegans TDP43: Nucleic Acid Binding Properties and Splicing Regulatory Function
  42. Corrigendum
  43. hnRNP H binding at the 5' splice site correlates with the pathological effect of two intronic mutations in the NF-1 and TSH  genes
  44. An Exonic Splicing Enhancer Offsets the Atypical GU-rich 3′ Splice Site of Human Apolipoprotein A-II Exon 3
  45. Genetic characterization of myeloperoxidase deficiency in Italy
  46. Identification and Subcellular Localization of Neuronal Calcium Sensor-1 (NCS-1) in Human Neutrophils and HL-60 Cells
  47. Genetic heterogeneity in Malattia Leventinese
  48. Regulation of 3′ Splice Site Selection in the 844ins68 Polymorphism of the Cystathionine β-Synthase Gene
  49. Minor Role for BRCA2 (Exon11) and p53 (Exon 5–9) Among Sudanese Breast Cancer Patients
  50. Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping
  51. Expression and characterization of recombinant human eosinophil peroxidase
  52. Functional Characterization of the Novel Mutation IVS 8 (−11delC) (−14T>A) in the Intron 8 of the Glucocerebrosidase Gene of Two Italian Siblings with Gaucher Disease Type I
  53. Splicing Factors Induce Cystic Fibrosis Transmembrane Regulator Exon 9 Skipping through a Nonevolutionary Conserved Intronic Element
  54. The A/G polymorphism in the −78 position of the apolipoprotein A-I promoter does not have a direct effect on transcriptional efficiency
  55. Hereditary eosinophil peroxidase deficiency: immunochemical and spectroscopic studies and evidence for a compound heterozygosity of the defect.
  56. cDNA clones of myeloperoxidase (MPO) and eosinophil peroxidase (EPO) from human blood mononuclear cells differentiated into granulocyte precursors in liquid cultures